American Chemical Society
am0c00914_si_001.pdf (555.99 kB)

Blood Group Antigen Shielding Facilitated by Selective Cell Surface Engineering

Download (555.99 kB)
journal contribution
posted on 2020-05-08, 19:06 authored by Long Jiang, Huajing Liu, Chuixiu Huang, Xiantao Shen
Production of red blood cells (RBCs) without immunogenicity of blood group antigens is of special interest in blood transfusion therapy in clinical chemistry. In this study, a selective cell surface engineering method was developed for the preparation of antigen-shielded RBCs based on molecular imprinting. Using an epitope imprinting method, biocompatible molecularly imprinted nanogels (MIgels) were prepared with a high affinity to the blood group antigens of RBCs. The antigen-shielded RBCs could avoid the agglutination caused by blood group mismatch, resulting in the antigen-shielded RBCs in efficiently substituting RBCs in case of a shortage of blood supply. Moreover, the antigen-shielded RBCs could maintain the normal physiological structure and functions of the original RBCs. We believe that the selective cell surface engineering presented in this work may offer significant benefits in specific cell protection for biomedical application.